1. |
Taylor ME, Haffty BG, Rabinovitch R, et al. ACR appropriateness criteria on postmastectomy radiotherapy expert panel on radiation oncology-breast. Int J Radiat Oncol Biol Phys, 2009, 73(4): 997-1002.
|
2. |
Recht A, Comen EA, Fine RE, et al. Postmastectomy radiotherapy: an American Society of Clinical Oncology, American Society for Radiation Oncology, and Society of Surgical Oncology Focused Guideline Update. J Clin Oncol, 2016, 34(36): 4431-4442.
|
3. |
Wang X, Zhang L, Zhang X, et al. Impact of clinical-pathological factors on locoregional recurrence in mastectomy patients with T1-2N1 breast cancer: who can omit adjuvant radiotherapy?. Breast Cancer Res Treat, 2021, 190(2): 277-286.
|
4. |
NCCN. NCCN clinical practice guidelines in oncology: breast cancer (Version12018). (2018-11-01). 2023-05-05. www. nccn. org/patients.
|
5. |
Kronowitz SJ, Robb GL. Breast reconstruction with postmastectomy radiation therapy: current issues. Plast Reconstr Surg, 2004, 114(4): 950-960.
|
6. |
陈诚, 谷成, 丁方回, 等. 乳腺癌患者乳房切除术后放射治疗对乳房重建影响的meta分析. 中国普外基础与临床杂志, 2022, 29(1): 78-84.
|
7. |
Kishan AU, McCloskey SA. Postmastectomy radiation therapy after neoadjuvant chemotherapy: review and interpretation of available data. Ther Adv Med Oncol, 2016, 8(1): 85-97.
|
8. |
樊莉, 陈茂山, 牟德武, 等. 基于SEER数据库分析腋窝淋巴结状态与初诊Ⅳ期乳腺癌预后的关系. 遵义医科大学学报, 2021, 44(4): 492-498.
|
9. |
Luo M, Chen H, Deng H, et al. Postmastectomy radiotherapy after neoadjuvant chemotherapy in cT1-2N+ breast cancer patients: a single center experience and review of current literature. Front Oncol, 2022, 12: 881047. doi: 10.3389/fonc.2022.881047.
|
10. |
Huang EH, Tucker SL, Strom EA, et al. Postmastectomy radiation improves local-regional control and survival for selected patients with locally advanced breast cancer treated with neoadjuvant chemotherapy and mastectomy. J Clin Oncol, 2004, 22(23): 4691-4699.
|
11. |
McGuire SE, Gonzalez-Angulo AM, Huang EH, et al. Postmastectomy radiation improves the outcome of patients with locally advanced breast cancer who achieve a pathologic complete response to neoadjuvant chemotherapy. Int J Radiat Oncol Biol Phys, 2007, 68(4): 1004-1009.
|
12. |
Le Scodan R, Selz J, Stevens D, et al. Radiotherapy for stage Ⅱ and stage Ⅲ breast cancer patients with negative lymph nodes after preoperative chemotherapy and mastectomy. Int J Radiat Oncol Biol Phys, 2012, 82(1): e1-e7.
|
13. |
Shim SJ, Park W, Huh SJ, et al. The role of postmastectomy radiation therapy after neoadjuvant chemotherapy in clinical stage Ⅱ-Ⅲ breast cancer patients with pN0: a multicenter, retrospective study (KROG 12-05). Int J Radiat Oncol Biol Phys, 2014, 88(1): 65-72.
|
14. |
Rusthoven CG, Rabinovitch RA, Jones BL, et al. The impact of postmastectomy and regional nodal radiation after neoadjuvant chemotherapy for clinically lymph node-positive breast cancer: a National Cancer Database (NCDB) analysis. Ann Oncol, 2016, 27(5): 818-827.
|
15. |
Cao L, Ou D, Shen KW, et al. Outcome of postmastectomy radiotherapy after primary systemic treatment in patients with clinical T1-2N1 breast cancer. Cancer Radiother, 2018, 22(1): 38-44.
|
16. |
铁剑, 张丝媛. 乳腺癌新辅助化疗后腋窝淋巴结1~3枚转移的患者改良根治术后放射治疗的疗效分析. 中华乳腺病杂志 (电子版), 2015, 9(3): 168-172.
|
17. |
贺春钰, 糟航, 木妮热·木沙江, 等. 新辅助化疗后N0的早期乳腺癌患者术后放疗的临床价值. 实用医学杂志, 2019, 35(17): 2761-2764.
|
18. |
孙丽云, 卢月, 张顺康, 等. cT1-2N1M0期乳腺癌新辅助化疗和改良根治术后腋窝淋巴结转移0~3枚患者术后放疗的生存分析. 国际肿瘤学杂志, 2020, 47(1): 10-17.
|
19. |
Kaššák F, Rossier C, Picardi C, et al. Postmastectomy radiotherapy in T1-2 patients with one to three positive lymph nodes - past, present and future. Breast, 2019, 48: 73-81.
|
20. |
Abdel-Rahman O. Impact of postmastectomy radiotherapy on the outcomes of breast cancer patients with T1-2 N1 disease : an individual patient data analysis of three clinical trials. Strahlenther Onkol, 2019 , 195(4): 297-305.
|
21. |
Kim SI, Cho SH, Lee JS, et al. Clinical relevance of lymph node ratio in breast cancer patients with one to three positive lymph nodes. Br J Cancer, 2013, 109(5): 1165-1171.
|
22. |
Park HJ, Shin KH, Kim JH, et al. Incorporating risk factors to identify the indication of post-mastectomy radiotherapy in N1 breast cancer treated with optimal systemic therapy: a multicenter analysis in Korea (KROG 14-23). Cancer Res Treat, 2017, 49(3): 739-747.
|
23. |
Yamada A, Hayashi N, Kumamaru H, et al. Prognostic impact of postoperative radiotherapy in patients with breast cancer and with pT1-2 and 1-3 lymph node metastases: a retrospective cohort study based on the Japanese Breast Cancer Registry. Eur J Cancer, 2022, 172: 31-40.
|
24. |
杨柯, 李天禹. CD2在乳腺癌肿瘤微环境中的作用及其预后意义. 遵义医科大学学报, 2021, 44(2): 201-211.
|
25. |
Menon H, Chen D, Ramapriyan R, et al. Influence of low-dose radiation on abscopal responses in patients receiving high-dose radiation and immunotherapy. J Immunother Cancer, 2019, 7(1): 237. doi: 10.1186/s40425-019-0718-6.
|
26. |
Herter-Sprie GS, Koyama S, Korideck H, et al. Synergy of radiotherapy and PD-1 blockade in Kras-mutant lung cancer. JCI Insight, 2016, 1(9): e87415. doi: 10.1172/jci.insight.87415.
|
27. |
张佳琪, 贾红燕. PD-1/PD-L1抑制剂在乳腺癌中的研究进展. 中国普外基础与临床杂志, 2021, 28(11): 1530-1535.
|
28. |
Demaria S, Coleman CN, Formenti SC. Radiotherapy: changing the game in immunotherapy. Trends Cancer, 2016, 2 (6): 286-294.
|
29. |
Liu L, Chen W, Zhang R, et al. Radiotherapy in combination with systemic therapies for brain metastases: current status and progress. Cancer Biol Med, 2020, 17(4): 910-922.
|
30. |
蒲虹羽, 高砚春, 侯令密. 乳房切除术后放射治疗在T1~2N1M0患者中的研究进展. 中国普外基础与临床杂志, 2022, 29(10): 1395-1400.
|